Healthspan podcast

94. Effects of Semaglutide on CKD in Patients with Type 2 Diabetes

7.10.2024
0:00
11:00
Spol 15 sekunder tilbage
Spol 15 sekunder frem

@ michaelsalzle Patients with diabetes and chronic disease are at high risk for kidney failure, cardiovascular events, and death. The FLOW trial looked at the safety and efficacy of semaglutide in patients with chronic disease and type 2 diabetes.

Flere episoder fra "Healthspan"